Moore, Richard G, et al. “A Novel Marker for the Management of Patients Diagnosed With Endometrial Adenocarcinoma of the Uterus: HE4 a Novel Serum Marker for Endometrial Cancer”. Clinical Journal of Obstetrics and Gynecology, Mar. 2026, pp. 001-7, doi:10.29328/journal.cjog.1001199.